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Maximal Exercise Electrocardiography Responses and
Coronary Heart Disease Mortality Among Men With
Diabetes Mellitus
G. William Lyerly, MS; Xuemei Sui, MD; Timothy S. Church, MD, PhD; Carl J. Lavie, MD;
Gregory A. Hand, PhD; Steven N. Blair, PED
Background—An abnormal ECG during maximal exercise testing has been shown to be a powerful predictor of future
coronary heart disease (CHD) mortality in asymptomatic men. However, little is known about the relationship between
exercise ECG responses and CHD risk in men with diabetes mellitus.
Methods and Results—We examined the association between exercise ECG responses and mortality in 2854 men with
documented diabetes mellitus (mean age 49.5 years) who completed a maximal treadmill exercise test during the period
from 1974 to 2001 and who were without a previous cardiovascular disease (CVD) event at baseline. Mortality due to
all causes, CHD, and CVD were the main outcome measures across categories of exercise ECG responses, with
stratification by cardiorespiratory fitness, quantified as treadmill test duration. During an average follow-up of 16 years,
441 deaths (210 CVD and 133 CHD) were identified. Across normal, equivocal, and abnormal exercise ECG groups,
age- and examination year–adjusted CHD mortality rates per 10 000 person-years were 23.0, 48.6, and 69.0, respectively
(Ptrend0.001). After further adjustment for fasting plasma glucose level, smoking, body mass index, hypercholester-
olemia, hypertension, family history of CVD or diabetes mellitus, abnormal resting ECG responses, and cardiorespi-
ratory fitness, hazard ratios (95% confidence intervals) were 1.00 (referent), 1.68 (1.01 to 2.77), and 2.21 (1.41 to 3.46;
Ptrend0.001). Similar patterns of associations were noted between exercise ECG testing and both CVD and all-cause
mortality risk.
Conclusions—Among men with diabetes mellitus, equivocal and abnormal exercise ECG responses were associated with
higher risk of all-cause, CVD, and CHD mortality. (Circulation. 2008;117:2734-2742.)
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The prevalence of diabetes mellitus in 2005 was 10.8million, affecting 7% of the total US population. In 2005
alone, 1.5 million new cases of diabetes mellitus were
reported and an estimated 1.1 million people died of diabetes
mellitus.1 Individuals with diabetes are known to have a 2 to
4 times higher risk of premature cardiovascular disease
(CVD) and death than individuals of the same age who do not
have diabetes mellitus.2,3 The risk of a CVD event in those
with diabetes is similar to that of persons with established
CVD. Therefore, a noninvasive diagnosis of subclinical CVD
in patients with diabetes mellitus is potentially important and
may optimize secondary preventative interventions in this
high-risk population.
Clinical Perspective p 2742
Although exercise testing is proven to have prognostic
value, studies examining the relationship between exercise
ECG responses and coronary heart disease (CHD) mortality
risk in asymptomatic men with existing CVD risk factors are
inconsistent. Most of the studies have shown a positive
association in high-risk subgroups,4–7 although others have
not.8 However, none of these studies focused on individuals
with diabetes mellitus, which is considered to be a CHD risk
equivalent. The American Heart Association examined this
issue and concluded that no outcome data were available to
show a benefit of early identification of asymptomatic CVD
in diabetic patients from exercise ECG testing.9 Indeed, data
on the relationship between exercise ECG tests and CVD/
CHD risk in diabetic men are sparse, and most studies used
small samples. Callaham et al10 studied 1747 US veterans
with diabetes mellitus and showed that exercise-induced
ST-segment depression was associated with more CVD
events during a mean 2 years of follow-up. In a study of 45
patients, Weiner et al11 reported that patients with diabetes
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with exercise-induced silent ischemia had worse outcomes in
terms of CVD events than persons without diabetes with
silent ischemia. Therefore, the primary aim of the present
study was to evaluate the relationship between exercise ECG
testing and CHD mortality in a large population of asymp-
tomatic men with diabetes mellitus. We showed previously
that a maximal exercise test performed in asymptomatic men
free of CVD can predict future risk of CHD death and that an
abnormal test was a more powerful predictor of risk in those
with than those without conventional risk factors.12 The
present study will expand this prior report and focus on men
with diabetes mellitus.
Methods
Population
All participants completed a baseline clinical examination during
1974 to 2001 at the Cooper Clinic (Dallas, Tex) and were enrolled in
the Aerobics Center Longitudinal Study. The participants had no
history or evidence of myocardial infarction or stroke, had a body
mass index 18.5 kg/m2, and had at least 1 year of follow-up data.
Other inclusion criteria for the present analyses were that participants
had completed a maximal treadmill test at baseline and had diabetes
mellitus, which was defined as fasting plasma glucose concentration
7.0 mmol/L (126 mg/dL), a history of physician diagnosis of the
disease, or insulin use.13 We identified 2854 men (21 to 84 years old)
with diabetes mellitus. We excluded women from the present
analysis because the small number of women with diabetes mellitus
in our clinic population precluded meaningful analyses. The majority
of men were white men from middle or upper socioeconomic strata.
All participants gave informed consent to participate in the clinical
examination and follow-up study. The Cooper Institute Institutional
Review Board reviewed and approved the study protocol annually.
Clinical Examination
The baseline examination was performed after a fast of at least 12
hours and included a physician examination and a thorough preven-
tive medical evaluation and clinical measurements. Body mass index
was computed from measured height and weight. Systolic and
diastolic blood pressures were recorded at rest, as the first and fifth
Korotkoff sounds, by standard auscultation methods.14 Hypertension
was defined as systolic blood pressure140 mm Hg, diastolic blood
pressure 90 mm Hg, or a history of physician diagnosis. Concen-
trations of total and high-density lipoprotein cholesterol, triglyceride,
and glucose were measured with automated bioassays in accordance
with the Centers for Disease Control and Prevention Lipid Standard-
ization Program. Family history of CVD or diabetes and smoking
habits were obtained from a standardized questionnaire. Resting
ECG was performed according to a standard manual of operations.
Conventional risk factors were defined according to American Heart
Association guidelines15: hypercholesterolemia (total cholesterol
6.20 mmol/L [240 mg/dL]), low high-density lipoprotein
(1.03 mmol/L [40 mg/dL]), hypertriglyceridemia (2.26 mmol/L
[200 mg/dL]), hypertension, current smoking, abnormal resting ECG
response, obesity (body mass index 30.0 kg/m2), and a family
history of premature CVD.
Exercise Test
A maximal symptom-limited treadmill exercise test was performed
with a modified Balke protocol.16,17 The treadmill test began with the
patient walking 88 m/min at 0% grade. At the end of the first minute,
elevation was increased to 2% and thereafter was increased 1% per
minute until the 25th minute. Beyond 25 minutes, elevation re-
mained constant, whereas speed was increased each minute by 5.4
m/min until exhaustion. The test end point was volitional exhaustion
or termination by the physician for medical reasons. The 12-lead
ECG was monitored continuously during exercise testing. Exercise
duration on this protocol is highly correlated with measured maximal
oxygen uptake(r0.92).18 Maximal metabolic equivalents (METs, 1
MET3.5 mL O2 uptake · kg1min1) were estimated from the final
treadmill speed and grade.19 We used our previously published
age-specific distribution of treadmill duration from the overall
Aerobics Center Longitudinal Study population to define fitness as
low fit (lowest 20%), moderately fit (middle 40%), or high fit (upper
40%) to maintain consistency with our previous reports and because
we have found that low fitness, defined in this way, is an independent
predictor of mortality20,21 and morbidity.22 In brief, treadmill-time
quintiles were determined for each age group (20 to 39, 40 to 49, 50
to 59, and 60 years). Men with a treadmill time in the first quintile
were assigned to the low-fit group. Those with scores in the second
through the third quintiles and scores in the fourth through the fifth
quintiles constituted moderate- and high-fit groups, respectively.
Thus, assignment to a fitness category was based on age norms of
treadmill performance rather than an absolute fitness standard. The
respective cut points for total treadmill time and METs in the low-,
moderate-, and high-fitness groups were described in detail in a
previous report.22 Heart rate recovery was defined as the heart rate
decline during the first 5 minutes after completion of the maximal
exercise test (maximal heart rate minus heart rate at 5 minutes of
recovery). Heart rate reserve was calculated as 220 minus age minus
resting heart rate.
Equivocal exercise ECG responses were those in which ST-
segment depression was present between 0.5 and 1.0 mm in
amplitude that lasted at least 0.08 seconds.17 Abnormal exercise
ECG responses included rhythm and conduction disturbances and
ischemic ST-T–wave abnormalities, as described in detail else-
where.12,17 Previously, to establish the percentage of abnormal tests
due to the major criteria of ST depression or elevation 1 mm that
lasted 0.08 second from the J point, 357 abnormal tests among
1436 abnormal tests identified in the database as abnormal were
randomly selected and reanalyzed by a group of 3 physicians. We
found that 90% of these randomly selected abnormal tests were
abnormal owing to ST depression or elevation with or without chest
pain, and the specificity of the testing was 90%.12
Mortality Surveillance
All participants were followed up from the date of their baseline
examination until their date of death or December 31, 2003. The
National Death Index was the primary data source for mortality
surveillance. The underlying cause of death was determined from the
National Death Index report or by a nosologist’s review of official
death certificates obtained from the department of vital records in the
decedent’s state of residence. Cardiovascular disease mortality was
defined by International Classification of Diseases, Ninth Revision
(ICD-9) codes 390 to 449.9 before 1999 and ICD-Tenth Revision
(ICD-10) codes I00 to I78 during 1999 to 2003. CHD mortality was
defined by ICD-9 codes 410 to 414 before 1999 and ICD-10 codes
I20 to I25 during 1999 to 2003. The average follow-up time was 15.8
years (SD9.6, range 1.3 to 30.0 years). We computed person-years
of follow-up as the sum of follow-up time among decedents and
survivors. In 45 093 person-years of follow-up, 441 deaths were
identified, of which 210 were due to CVD and 133 to CHD.
Statistical Analysis
Baseline characteristics of the population were examined by exercise
ECG category (differences in covariates were tested by Student’s t
tests for continuous variables and 2 tests for categorical variables in
Table 1) and by vital status (differences in covariates were tested
with F tests for all variables in Table 1). The associations of exercise
ECG testing with the risk of mortality were analyzed with risk
factor–adjusted Cox proportional hazards models. The dependent
variable was time to development of death of all causes, CVD, or
CHD. The independent variable was exercise ECG group. Risk
factors included baseline measures: age (in years), examination year,
fasting glucose level (mg/dL), smoking status (current smoker or
not), body mass index (kg/m2), hypercholesterolemia (yes or no),
hypertension (present or not), abnormal resting ECG responses
(present or not), family history of CVD or diabetes (present or not for
each), heart rate reserve, and treadmill time (minutes). Tests of linear
Lyerly et al Exercise ECG Predicts CHD Among Men With Diabetes 2735
 at University of South Carolina--Columbia on June 11, 2013http://circ.ahajournals.org/Downloaded from 
trends across risk factor categories were computed by integer scoring
(values 1, 2, and 3) for the 3 categories.
Cumulative hazard plots grouped by exposures suggested no
appreciable violations of the proportional hazards assumption. We
excluded events that occurred during the first year of follow-up to
reduce potential confounding caused by procedure-related deaths and
the potential influence of undetected subclinical disease at baseline.
For survival analyses for the fitness and exercise ECG testing
combinations, we combined moderately and highly fit men into a fit
group; low-fit men were designated as the unfit group (20 to 39 years
old, 10.4 METs; 40 to 49 years, 9.9 METs; 50 to 59 years, 8.5
METs; 60 years, 7.2 METs). This allowed us to create the
following 6 categories: normal ECG-fit; equivocal ECG-fit; abnor-
mal ECG-fit; normal ECG-unfit; equivocal ECG-unfit; and abnormal
ECG-unfit. Kaplan–Meier survival curves were generated by the
above combinations for CVD and CHD mortality. Crude and
multivariate-adjusted log-rank tests were used to determine signifi-
cance. All tests for statistical significance were 2-sided. A probabil-
ity value 0.05 was considered significant. All statistical analyses
were performed with SAS statistical software, version 9.1 (SAS Inc,
Cary, NC).
The authors had full access to and take full responsibility for the
integrity of the data. All authors have read and agree to the
manuscript as written.
Results
At baseline, the mean age (SD) of the study participants
was 49.59.7 years, mean treadmill test duration was
14.95.1 minutes, and mean maximal METs was 10.22.4.
The prevalence of unfit subjects was 28.9%. Table 1 shows
baseline characteristics based on vital status and exercise
ECG results. Workload achieved (METs) was higher in
survivors and normal exercise ECG groups, whereas age,
systolic blood pressure, heart rate recovery, and heart rate
reserve were greater and current smoking, hypertension,
family history of CVD, and abnormal resting ECGs occurred
more frequently in decedents and abnormal exercise ECG
groups.
We examined age- and examination year–adjusted relative
risk for mortality due to all causes, CVD, and CHD (Table 2).
Exercise ECG test results were a strong predictor of CHD
mortality risk (hazard ratio [HR] 2.11, 95% confidence
interval [CI] 1.29 to 3.46 for equivocal ECG and HR 3.00,
95% CI 1.95 to 4.61 for abnormal ECG, Ptrend0.001). The
other predictors of CHD death were abnormal resting ECG
(HR 2.13, 95% CI 1.28 to 3.54), obesity (HR 2.81, 95% CI
1.76 to 4.51), hypertension (HR 2.15, 95% CI 1.50 to 3.08),
and hypercholesterolemia (HR 1.46, 95% CI 1.04 to 2.07).
The HR (95% CI) for CHD mortality associated with each
1-MET increment was 0.79 (0.73 to 0.86), and it was 0.43
(0.30 to 0.64) and 0.30 (0.19 to 0.48) in moderately and
highly fit men, respectively, compared with the low-fit group.
Table 1. Baseline Characteristics of 2854 Men With Diabetes Mellitus According to Vital Status and Exercise ECG Testing Outcomes,
Aerobics Center Longitudinal Study, 1974–2003
Vital Status Exercise ECG Testing
Characteristic
Survivors
(n2413)
Decedents
(n441) P
Normal
(n2247)
Equivocal
(n304)
Abnormal
(n303)
P for
Trend
Age, y 48.69.6 54.29.3 0.001 47.99.3 53.69.4 56.98.5 0.001
Follow-up, y 15.89.9 15.67.8 0.72 16.39.8 13.98.7 13.48.6 0.001
Body mass index, kg/m2 28.04.7 27.85.6 0.56 27.84.7 28.94.9 28.25.9 0.001
Workload achieved, METs 10.52.3 9.02.4 0.001 10.62.4 9.22.1 8.72.1 0.001
Lipids, mmol/L
Total cholesterol 5.72.2 6.01.2 0.001 5.72.3 5.71.2 5.81.3 0.79
HDL cholesterol 1.10.5 1.00.3 0.001 1.10.5 1.00.3 1.10.3 0.007
Triglycerides 2.12.7 2.53.1 0.03 2.12.1 2.52.4 2.51.8 0.008
Fasting blood glucose, mmol/L 7.32.7 8.03.3 0.001 7.22.7 8.23.2 8.13.0 0.001
Resting blood pressure, mm Hg
Systolic 12615 13117 0.001 12514 13218 13418 0.001
Diastolic 8410 8411 0.25 8410 8611 8510 0.001
Maximal blood pressure, mm Hg
Systolic 19326 19428 0.49 19125 20031 19930 0.001
Diastolic 8014 8413 0.001 8013 8515 8414 0.001
Resting heart rate, bpm 6411 6613 0.001 6411 6511 6512 0.14
Maximal heart rate, bpm 17217 16420 0.001 17416 16419 15921 0.001
Heart rate at 5 min of recovery, bpm 10915 10215 0.001 10914 10616 10218 0.001
Heart rate reserve, bpm 10820 9822 0.001 11019 9920 9423 0.001
Current smoker, % 17.9 22.7 0.02 19.8 13.5 14.9 0.006
Hypertension, % 40.9 57.8 0.001 39.6 57.9 58.4 0.001
Family history of diabetes mellitus, % 11.9 3.0 0.001 9.9 11.2 13.9 0.10
Parental history of premature CVD, % 32.0 42.0 0.001 32.4 35.5 39.9 0.02
Abnormal resting ECG, % 5.5 10.0 0.001 3.9 11.2 18.2 0.001
Data shown as meanSD unless specified otherwise.
2736 Circulation May 27, 2008
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Patterns and magnitude of the association between exposure
variables and all-cause and CVD mortality risk were similar
to those for CHD (Table 2).
Table 3 shows a positive gradient (Ptrend0.001) of CHD,
CVD, and all-cause mortality rates across exercise ECG
groups. After adjustment for risk factors, men with equivocal
and abnormal exercise ECG tests had a 68% and 121% higher
CHD death risk (Ptrend0.001), a 63% and 103% higher risk
of CVD death (Ptrend0.001), and a 41% and 44% higher risk
of all-cause death (Ptrend0.003) than men with a normal ECG
test, respectively.
We then examined whether other risk predictors modified
the association between exercise ECG responses and CHD
mortality (Table 4). The positive associations between exer-
cise ECG testing and CHD risk were evident in categories of
other risk factors, except that there appeared to be a stronger
risk among men with abnormal resting ECG responses,
although the test for interaction was not significant (P for
interaction0.92). This may be due to the small number of
CHD deaths in this group (only 3, 7, and 9 CHD deaths
occurred across normal, equivocal, and abnormal ECG exer-
cise groups, respectively). The consistency in the direction
and magnitude of association between exercise ECG testing
and CHD suggested that little effect modification was present
across most of the risk factor categories. We also performed
stratified analyses on CVD mortality risk, with the pattern
being similar (data not shown).
Statistical evidence existed of an interaction between
exercise ECG responses and cardiorespiratory fitness (CRF)
in predicting CHD death (217.18, P0.001). Therefore,
we examined the joint association of exercise ECG testing
and CRF level on CHD mortality (Figure 1). The prevalence
of abnormal ECG testing was higher in unfit men (13.9%)
than in fit men (9.3%). We observed positive gradients of
CHD death rates across exercise ECG testing results within
fit or unfit groups (P0.01 each). The differences in CHD
survival over time by the 6 exercise ECG testing–fitness
groups are shown in Figure 2. After adjustment for all risk
factors, the resulting log-rank test did not change materially
(280.56, P0.001). Individuals who had a normal exercise
Table 2. Age- and Examination Year–Adjusted HRs of All-Cause, CVD, and CHD Death According to
Exercise ECG Testing Results and Other Potential CVD Risk Factors in 2854 Men With Diabetes Mellitus
Variable All-Cause HR (95% CI) CVD HR (95% CI) CHD HR (95% CI)
Exercise ECG testing
Normal 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)
Equivocal 1.70 (1.30–2.22) 2.01 (1.37–2.96) 2.11 (1.29–3.46)
Abnormal 1.77 (1.37–2.29) 2.59 (1.84–3.66) 3.00 (1.95–4.61)
P linear trend 0.001 0.001 0.001
Workload achieved, per 1-MET increment 0.81 (0.78–0.85) 0.81 (0.76–0.86) 0.79 (0.73–0.86)
CRF
Low fit 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)
Moderate fit 0.46 (0.37–0.57) 0.47 (0.34–0.63) 0.43 (0.30–0.64)
High fit 0.34 (0.26–0.43) 0.32 (0.22–0.47) 0.30 (0.19–0.48)
P linear trend 0.001 0.001 0.001
Resting heart rate, per 10 bpm 1.24 (1.15–1.34) 1.26 (1.12–1.41) 1.23 (1.06–1.42)
Maximal heart rate, per 10 bpm 0.82 (0.78–0.87) 0.79 (0.74–0.86) 0.77 (0.70–0.84)
Heart rate at 5 min of recovery, per 10 bpm 0.96 (0.90–1.03) 0.93 (0.84–1.03) 0.92 (0.81–1.04)
Heart rate reserve, per 10 bpm 0.81 (0.77–0.84) 0.78 (0.73–0.84) 0.77 (0.71–0.84)
Maximal systolic blood pressure, per 10 mm Hg 1.06 (1.02–1.10) 1.06 (1.00–1.12) 1.08 (1.01–1.15)
Maximal diastolic blood pressure, per 10 mm Hg 1.13 (1.06–1.21) 1.18 (1.07–1.30) 1.14 (1.01–1.30)
Body mass index, kg/m2
18.5–24.9 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)
25.0–29.9 1.31 (1.05–1.63) 1.39 (1.00–1.93) 1.40 (0.92–2.13)
30.0 2.26 (1.74–2.93) 2.43 (1.66–3.56) 2.81 (1.76–4.51)
P linear trend 0.001 0.001 0.001
Current smoker 1.45 (1.16–1.82) 1.72 (1.25–2.35) 1.43 (0.95–2.15)
Hypertension 1.56 (1.29–1.89) 1.99 (1.50–2.64) 2.15 (1.50–3.08)
Hypercholesterolemia* 1.34 (1.11–1.63) 1.41 (1.07–1.86) 1.46 (1.04–2.07)
Low HDL cholesterol† 1.01 (0.83–1.48) 1.33 (0.87–2.04) 1.39 (0.79–2.44)
Hypertriglyceridemia‡ 1.45 (1.18–1.77) 1.31 (0.98–1.76) 1.40 (0.97–2.02)
Abnormal resting ECG 1.25 (0.91–1.73) 1.90 (1.26–2.87) 2.13 (1.28–3.54)
*Hypercholesterolemia is defined as total cholesterol 6.20 mmol/L (240 mg/dL).
†Low HDL cholesterol is defined as 1.03 mmol/L (40 mg/dL).
‡Hypertriglyceridemia is defined as triglyceride 2.26 mmol/L (200 mg/dL).
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ECG and were fit had the best survival. Those with an
abnormal exercise ECG, especially the unfit men, had the
lowest survival rates during follow-up. Survival rates were
higher among fit men than unfit men in each of the exercise
ECG result groups. The Kaplan–Meier curves were similar
when we analyzed CVD mortality rates across these 6 groups
(data not shown).
To further examine whether exercise ECG testing had
prognostic value beyond an individual’s pretest probability of
having a CHD event, we computed CHD mortality rates by
exercise ECG test results grouped on the number of major
conventional CVD risk factors at baseline (Figure 3). As
expected, those with more risk factors and an abnormal
exercise ECG had higher CHD mortality. We observed
positive gradients for CHD mortality rates across exercise
ECG categories within the 0 to 1 and 3 or more risk factor
groups, but the trend in men with 2 risk factors was not
significant. CVD mortality followed a similar pattern (data
not shown).
Discussion
Individuals with diabetes mellitus have been reported to have
a 2 to 4 times higher risk of CVD and death than individuals
of the same age who do not have diabetes mellitus.2,3 We
previously reported that an abnormal exercise test is associ-
ated with higher risk of CHD mortality in asymptomatic men
and that this relation is evident within different risk factor
groups.12 Exercise testing has not been recommended for
patients with diabetes mellitus9 because diabetes mellitus is
considered a CHD “risk equivalent,” and it has been assumed
that little additional information would be obtained from
exercise testing. Therefore, the primary aim of the present
report was to expand on our previous report12 and to deter-
mine whether exercise testing improves risk stratification in
men with diabetes mellitus. Our hypothesis was that an
equivocal or abnormal exercise ECG in men with diabetes
mellitus would be associated with a higher risk of all-cause,
CVD, and CHD mortality than among those who had a
normal exercise ECG. We observed a direct gradient of
mortality risk across normal, equivocal, and abnormal exer-
cise ECG groups, and this remained significant after adjust-
ment for age, smoking, family history of CVD or diabetes,
abnormal resting ECG responses, fasting glucose level, CRF,
and factors that may be intermediate in the causal pathway
between exercise ECG and CHD (body mass index, hyper-
tension, and hypercholesterolemia). A second major finding
was that the association between exercise ECG result and
CHD generally was consistent within strata of other CHD
predictors. The prognostic value of an abnormal exercise
ECG was particularly notable in men with other coexisting
risk factors at baseline. A third noteworthy issue was that fit
men had a higher survival rate than unfit men within each
category of exercise ECG outcome.
Because of their propensity for silent ischemia, patients
with diabetes mellitus may require special consideration.
Callaham et al10 studied 1747 US veterans with diabetes and
showed that exercise-induced ST-segment depression was
associated with more CVD events during a mean 2 years of
follow-up. Weiner et al11 reported that 45 patients with
diabetes mellitus who had exercise-induced silent ischemia
had worse outcomes in terms of CVD events than persons
without diabetes mellitus but with silent ischemia. May and
colleagues23 estimated the prevalence of maximal symptom-
limited bicycle ergometer exercise–induced silent ischemia in
those with diabetes mellitus was 13.5%. In the present study,
20% of men with diabetes had abnormal or equivocal
exercise ECG responses. Thus, those with diabetes mellitus
and an abnormal ECG may potentially benefit from further
attention.
Our finding on the positive relation between abnormal
exercise ECG results and higher risk for CHD mortality are in
concert with other population-based studies of asymptomatic
men with other CVD risk factors.4–7 Laukkanen and col-
leagues4 examined 1769 middle-aged men using a maximal
symptom-limited exercise stress test and found that exercise-
induced silent ischemia was associated with adverse outcome
largely in those who were at high risk of developing CHD
because of the presence of smoking, hypercholesterolemia, or
hypertension. The Framingham Heart Study Offspring Study
evaluated 3043 asymptomatic men and women, all of whom
underwent a symptom-limited exercise test and were fol-
lowed up for 18.2 years.5 ST-segment depression provided
additional prognostic information in age- and Framingham
risk score–adjusted models in men, particularly among those
in the highest-risk group (10-year predicted CHD risk
20%).5 Bruce et al6 found a 3-fold higher risk of CHD
among patients with 1 or more risk factors and 2 or more
abnormal features on exercise testing. Rywik et al7 reported
Table 3. Rates and HRs for All-Cause, CVD, and CHD Mortality
by Exercise ECG Results in 2854 Men With Diabetes Mellitus
Model 1† Model 2‡
No. of
Deaths Rate* HR 95% CI HR 95% CI
All causes
Normal 288 86.4 1.00 Referent 1.00 Referent
Equivocal 68 146.5 1.70 1.30–2.22 1.43 1.08–1.88
Abnormal 85 153.1 1.77 1.37–2.29 1.42 1.09–1.85
P linear trend 0.001 0.004
CVD
Normal 125 37.7 1.00 Referent 1.00 Referent
Equivocal 34 75.8 2.01 1.37–2.96 1.65 1.11–2.46
Abnormal 51 97.7 2.59 1.84–3.66 1.97 1.37–2.83
P linear trend 0.001 0.001
CHD
Normal 78 23.0 1.00 Referent 1.00 Referent
Equivocal 21 48.6 2.11 1.29–3.46 1.69 1.03–2.80
Abnormal 34 69.0 3.00 1.95–4.61 2.11 1.34–3.32
P linear trend 0.001 0.001
*Rate per 10 000 person-years adjusted for age and examination year.
†Adjusted for age and examination year.
‡Adjusted for the above plus fasting glucose level, current smoking (yes or
no), body mass index, hypercholesterolemia (yes or no), hypertension (present
or not), family history of CVD or diabetes mellitus (present or not for each),
abnormal resting ECG responses (present or not), heart rate reserve, and
treadmill time duration.
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that abnormal exercise ECG responses (1 mm horizontal or
downsloping ST-segment depression) were associated with a
doubling of risk for CHD events. However, some studies
have failed to confirm a positive relation between abnormal
exercise ECG testing and CHD outcomes.8 For example,
Bodegard et al8 found that impaired breathing, not the
exercise ECG result, predicted a high long-term risk of CHD
mortality.
A few previous studies have reported the usefulness of
exercise testing for predicting CHD in patients with diabetes
mellitus.24,25 Elhendy et al24 evaluated the importance of
exercise echocardiography for risk stratification of such
patients with known or suspected ischemic heart disease. A
total of 563 patients underwent symptom-limited treadmill
testing that involved 1 of the 3 following protocols: Bruce,
Naughton, or modified Bruce. Their data indicated that
patients with diabetes mellitus who had an abnormal stress
echocardiogram were at greater risk of death or nonfatal
myocardial infarction than those with a normal stress echo-
cardiogram.24 Lee and colleagues25 sought to determine the
characteristics of exercise treadmill testing in patients with
diabetes who had angina. They conducted a retrospective
analysis of exercise test results in 1282 men who had
undergone coronary angioplasty and were without prior
myocardial infarction. They concluded that a standard exer-
cise test has similar diagnostic characteristics in patients with
diabetes mellitus and in those free of the disease.
Exercise testing is also an important predictor of survival.
Prakash et al26 tested 6213 men referred for a standard
maximal exercise ECG treadmill test because of complaints
of angina or because they had risk factors or signs or
symptoms of CHD. They found that abnormal exercise ECGs
were significantly more common in those who died during
follow-up, and exercise capacity (5 METS) was indepen-
dently and significantly associated with all-cause mortality.
The present findings are consistent with this report: Men with
Table 4. HRs for CHD Mortality According to Potential Risk Factor Categories by Exercise ECG Results in
2854 Men With Diabetes Mellitus
Exercise ECG Testing
Equivocal Abnormal
Normal HR 95% CI HR 95% CI P for Trend
Age, y*
55 1.00 2.10 1.01–4.37 2.57 1.17–5.64 0.005
55 1.00 1.60 0.80–3.20 2.68 1.49–4.81 0.001
CRF†
Low 1.00 1.87 0.97–3.61 1.84 0.97–3.50 0.04
Moderate 1.00 1.20 0.44–3.29 2.61 1.22–5.56 0.02
High 1.00 1.96 0.54–7.12 3.41 1.10–10.59 0.03
Current smoker†
No 1.00 1.81 1.03–3.18 2.43 1.49–3.95 0.001
Yes 1.00 1.35 0.44–4.17 1.55 0.50–4.84 0.40
Family history of CVD†
No 1.00 1.74 0.92–3.28 2.35 1.30–4.25 0.003
Yes 1.00 2.26 1.01–5.06 2.44 1.23–4.85 0.006
Resting ECG responses†
Normal 1.00 1.36 0.76–2.44 2.32 1.42–3.78 0.001
Abnormal 1.00 12.63 2.10–75.94 4.99 1.21–20.62 0.05
Body mass index, kg/m2†
18.5–24.9 1.00 1.59 0.56–4.57 2.31 0.92–5.80 0.07
25.0 1.00 1.79 1.01–3.17 2.30 1.39–3.82 0.001
Hypertension†
No 1.00 1.26 0.47–3.35 2.63 1.18–5.84 0.02
Yes 1.00 2.01 1.11–3.61 2.34 1.38–3.98 0.001
Total cholesterol†
6.20 mmol/L (240 mg/dl) 1.00 2.42 1.27–4.61 2.95 1.61–5.40 0.001
6.20 mmol/L (240 mg/dl) 1.00 1.12 0.50–2.53 1.83 0.94–3.58 0.09
Triglycerides†
2.26 mmol/L (200 mg/dL) 1.00 1.52 0.78–2.96 2.32 1.37–3.95 0.002
2.26 mmol/L (200 mg/dL) 1.00 2.13 0.97–4.69 2.18 0.97–4.91 0.03
*Adjusted for examination year, glucose level, and each of the other risk factors (except age) in the Table.
†Adjusted for examination year, glucose level, and each of the other risk factors in the Table.
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higher CRF levels have a higher survival rate than unfit men,
and an abnormal exercise ECG is associated with an in-
creased risk of all-cause mortality. These findings further
demonstrate the prognostic power of exercise testing, includ-
ing both the ECG response and the CRF assessment.
Results from the Aerobics Center Longitudinal Study have
shown that low levels of CRF are independently associated
with increased mortality in men with diabetes mellitus.2,27,28
In the present investigation, we found that men with diabetes
who were unfit but had normal ECG testing had lower CHD
mortality risk than men with diabetes who were fit but had
equivocal or abnormal ECG testing. This finding further
demonstrates the prognostic power of the exercise ECG
response even in fit men with diabetes mellitus. Strengthen-
ing the public health importance of our findings, we observed
that 26% of unfit men with diabetes had normal exercise ECG
tests, which provides further evidence for the importance of
the exercise ECG. To the best of our knowledge, no studies
have examined the joint association of exercise ECG results
and exercise capacity on CHD risks in men with diabetes
mellitus. The present results provide evidence of an intrinsic
value in encouraging healthcare professionals to perform a
treadmill test to determine diabetic patients’ CRF level and
exercise ECG response, which may guide both physical
activity counseling and CHD prevention efforts.
Strengths of the present study include the extensive base-
line examination to detect subclinical disease, the use of
measured risk factors, the variety of mortality end points, the
relatively long follow-up (average 15 years), the broad age
range of the study population (from 21 to 82 years), and the
fact that we studied the prognostic impact of an exercise ECG
stress test. In the present study, all stress tests were maximal
tests, and ECGs were monitored continually with 12 leads for
10 minutes after the conclusion of each test.12,17 Therefore,
our methods ensured that we would capture most, if not all,
abnormalities that may have occurred.
One limitation of the present study was the absence of data
documenting the duration of diabetes in the study subjects.
Figure 1. Age- and examination year–adjusted CHD mortality
rates by fitness levels and exercise ECG results in 2854 men
with diabetes mellitus. Open bars represent normal ECG; striped
bars, equivocal ECG; and solid bars, abnormal ECG. P values
are for a test of linear trend across ECG results.
Figure 2. Survival free of CHD across exercise
ECG results and fitness status in a mean
16-year follow-up study of 2854 men with dia-
betes mellitus.
Figure 3. Age- and examination year–adjusted CHD mortality
rates (per 10 000 person-years) by exercise ECG results and
number of major conventional CVD risk factors (current smok-
ing, hypertension, hypercholesterolemia, family history of CVD,
abnormal resting ECG response, and obesity) in 2854 men with
diabetes mellitus. Open bars represent normal ECG; striped
bars, equivocal ECG; and solid bars, abnormal ECG. P values
are for a test of linear trend across ECG groups. The number of
men (and CHD deaths) in the normal, equivocal, and abnormal
ECG groups were 1212 (24), 123 (5), and 111 (10) in those with
0 or 1 risk factors; 624 (29), 86 (5), and 107 (8) in those with 2
risk factors; and 411 (25), 95 (11), and 85 (16) in those with 3
risk factors, respectively.
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However, the literature shows that half of the prevalent cases
of diabetes mellitus are undiagnosed and exist in patients
without typical clinical symptoms.29 Similarly, in the present
report, it is difficult to know exactly when these men were
diagnosed with diabetes mellitus. Although it is impossible
for us to directly assess the impact of the duration of diabetes
on the results, we did adjust the examination year when they
were identified as having diabetes mellitus. Although we
were unable to separate individuals with type 1 versus type 2
diabetes mellitus, previous reports suggest that 90% of
adults with diabetes have type 2 diabetes.30 Because the
present study consisted of middle-aged men, we suspect most
of the cases were type 2 diabetes. Another limitation was the
predominantly white, well-educated, middle- to upper-class,
and male subject group, which limits the ability to generalize
the results of the present study. However, this should not
affect the internal validity, and no strong reason exists to
assume that the benefits of exercise testing would be any less
in women or other ethnic groups. Our previous studies have
shown, in analyses in which enough deaths occurred for
parallel analyses in women and men, that the inverse gradient
of mortality across exercise capacity is similar for the 2
sexes.20,21,28,31 We do not have enough information for Duke
treadmill score calculations. The present study did not have
information on medication usage, dietary habits, hemoglobin
A1C levels, or presence of end-organ damage to include these
in our analysis. Although mortality data were primarily
obtained from the National Death Index, which has estab-
lished validity, the possibility still exists of misclassification
of CVD and CHD deaths. However, these issues of death
certificate analyses are not relevant for all-cause mortality,
which in the present study showed results similar to CVD and
CHD mortality. The consistency of results for all-cause,
CVD, and CHD mortality is reassuring, and therefore, we do
not think these issues would cause major misinterpretation of
the data. Finally, we do not have available information on the
sensitivity of the ECG test. Future studies are needed to
include these data to confirm the findings reported here.
In conclusion, abnormal exercise ECG response is a
significant determinant of CHD mortality in men with diabe-
tes mellitus. Assessment of exercise ECG by maximal stress
testing provides important prognostic information indepen-
dent of CRF level and traditional CHD risk factors. Exercise
stress testing to determine both ECG responses and CRF may
be used as a tool for potential CHD risk stratification in men
with diabetes mellitus. We encourage clinicians to further
consider the diagnostic value of maximal exercise ECG tests
for this high-risk group of men.
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CLINICAL PERSPECTIVE
Although exercise testing is proven to have prognostic value, studies that examine the relationship between exercise ECG
(E-ECG) responses and coronary heart disease (CHD) mortality risk in asymptomatic men with existing cardiovascular
disease risk factors are inconsistent. Most studies have shown a positive association in high-risk subgroups, although others
have not. However, these studies have not focused on individuals with diabetes mellitus, which is considered a CHD risk
equivalent. Therefore, the primary aim of our study was to evaluate the relationship between E-ECG testing and CHD
mortality in a large population of asymptomatic men with diabetes mellitus. We examined the association between E-ECG
responses and mortality in men with documented diabetes who completed a maximal treadmill exercise test and were
without a previous cardiovascular disease event at baseline. We observed a direct gradient of mortality risk across normal,
equivocal, and abnormal E-ECG groups that remained significant after adjustment for age, smoking, family history of
cardiovascular disease or diabetes mellitus, abnormal resting ECG responses, fasting glucose level, cardiorespiratory
fitness, and factors that may be intermediate in the causal pathway between E-ECG and CHD (body mass index,
hypertension, and hypercholesterolemia). A second major finding was that the association between E-ECG result and CHD
generally was consistent within strata of other CHD predictors. A third noteworthy issue was that fit men had a higher
survival rate than unfit men within each category of E-ECG outcome. Our data suggest that abnormal E-ECG response is
a significant determinant of CHD mortality in men with diabetes mellitus.
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